<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item#</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders">Other Treatment (CoC)<br/>Other Cancer-Directed Therapy (SEER/pre-96 CoC)</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1420</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">SEER/CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1591-1591</td>
    </tr>
</table>

<br/><b>Description</b><br/>
Identifies other treatment given at all facilities that cannot be defined as surgery, radiation, or systemic therapy according to the defined data items in this manual. Treatment for reportable hematopoietic diseases can be supportive care, observation, or any treatment that does not meet the usual definition in which treatment modifies, controls, removes, or destroys proliferating cancer tissue. Such treatments include phlebotomy, transfusions, and aspirin.

<br/><br/><b>Rationale</b><br/>
Information on other therapy is used to describe and evaluate the quality-of-care and treatment practices.

<br/><br/><b>Codes (Refer to the most recent version  of <i>FORDS</i> for additional coding instructions)</b><br/>
<table class="naaccr-codes-table">
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">0</td>
        <td class="naaccr-codes-cell">None</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">1</td>
        <td class="naaccr-codes-cell">Other</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">2</td>
        <td class="naaccr-codes-cell">Other Experimental</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">3</td>
        <td class="naaccr-codes-cell">Other-Double Blind</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">6</td>
        <td class="naaccr-codes-cell">Other-Unproven</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">7</td>
        <td class="naaccr-codes-cell">Refusal</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">8</td>
        <td class="naaccr-codes-cell">Recommended</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">9</td>
        <td class="naaccr-codes-cell">Unknown; unknown if administered</td>
    </tr>
</table>
